Katsumi Iga
18Patents
14h-index
17Co-inventors
71Inventor score
Filing activity: Nov 21, 1986 → Feb 18, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4877561A | Method of producing liposome | Emerging Cross-Sectional Technologies | 121 | Expired |
| US4844904A | Liposome composition | Emerging Cross-Sectional Technologies | 115 | Expired |
| US5094854A | Liposome composition useful for hypertheria therapy | Emerging Cross-Sectional Technologies | 101 | Expired |
| US5000959A | Liposome composition and production thereof | Human Necessities | 60 | Expired |
| US5750100A | Sustained releasable parenteral pharmaceutical preparations and method of producing the same | Human Necessities | 55 | Expired |
| US5019394A | Liposome composition and its production | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5993848A | Dissolution liquid for drug in iontophoresis | Human Necessities | 39 | Expired |
| US5628993A | Sustained releasable parenteral pharmaceutical preparations and method of producing the same | Human Necessities | 31 | Expired |
| US6526316B2 | Iontophoresis method | Human Necessities | 21 | Expired |
| US5837281A | Stabilized interface for iontophoresis | Human Necessities | 19 | Expired |
| US5700481A | Transdermal drug delivery process | Human Necessities | 18 | Expired |
| US5080904A | Liposome composition and its production | Human Necessities | 18 | Expired |
| US6322550A | Method for transdermal administration of GP IIb/IIIa antagonist | Human Necessities | 16 | Expired |
| US6743432B1 | Interface for iontophoresis | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6416503B1 | Matrix for iontophoreses | Human Necessities | 7 | Expired |
| US6248349A | Dissolution liquid for drug in iontophoresis | Human Necessities | 7 | Expired |
| US5252336A | Liposome composition whose liposome membrane contains a polyoxyethylene derivative | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7378108B1 | Percutaneous absorption preparation of compound having angiotensin II antagonistic activity | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.